J Neurol Surg B Skull Base 2024; 85(03): 227-233
DOI: 10.1055/s-0043-1764379
Original Article

MicroRNA-375-3p Alleviates Salicylate-Induced Neuronal Injury by Targeting ELAVL4 in Tinnitus

Jingjing Zhu
1   Department of ENT, The First Affiliated Hospital of Yangtze University, Jingzhou, China
,
Zhen Chen
2   Department of Emergency, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
Bo Yu
2   Department of Emergency, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
3   Department of Cardiovascular, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China
,
Fen Ai
2   Department of Emergency, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
› Author Affiliations
Funding This work was supported by Medical Research Fund of Wuhan Health and Health Commission, Youth Project (Approval Number: WX19Q15).

Abstract

Purpose Tinnitus is a phantom perception of sound in the absence of acoustic source. Previous evidence has indicated that miR-375-3p is downregulated in rats with tinnitus in comparison to the controls. Nevertheless, its molecular mechanism underlying tinnitus pathogenesis is unclarified.

Methods SH-SY5Y cells were differentiated into neuronlike cells and stimulated with salicylate to mimic tinnitus in vitro. Immunofluorescence staining was utilized for measuring expression of NR2B (glutamate ionotropic receptor NMDA type subunit 2B). Intracellular reactive oxygen species (ROS) level was determined using DCFH-DA assay kit. Real-time quantitative polymerase chain reaction as well as western blotting was utilized for examining RNA and protein levels. Luciferase reporter assay was implemented for verifying the interaction between miR-375-3p and ELAVL4 (ELAV-like RNA-binding protein 4).

Results Salicylate treatment enhanced levels of NR2B and the early immediate gene ARC as well as ROS production. miR-375-3p was downregulated in salicylate-treated group. Overexpressing miR-375-3p attenuated the effects induced by salicylate in SH-SY5Y cells. miR-375-3p targeted ELAVL4 and upregulating ELAVL4 reversed miR-375-3p upregulation–triggered effects on SH-SY5Y cells under salicylate treatment.

Conclusion miR-375-3p mitigates salicylate-triggered neuronal injury in SH-SY5Y cells by regulating ELAVL4 expression.

Author Contributions

J. Z. was the main designer of this study. Z. C., J. Z., and B. Y. performed the experiments and analyzed the data. L. Z., J. Z., and F. A. drafted the manuscript. All authors read and approved the final manuscript.


Data Availability Statement

The datasets used or analyzed during the current study are available from the corresponding author upon reasonable request.




Publication History

Received: 22 December 2022

Accepted: 05 February 2023

Article published online:
20 March 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Scott LL, Lowe AS, Brecht EJ, Franco-Waite L, Walton JP. Small molecule modulation of the large-conductance calcium-activated potassium channel suppresses salicylate-induced tinnitus in mice. Front Neurosci 2022; 16: 763855
  • 2 Tang D, Wang K, Ye Z. et al. The Fudan Tinnitus Relieving System (FTRS): the initial results of a smartphone application for tinnitus management and treatment. Internet Interv 2022; 29: 100564
  • 3 Kim HJ, Lee HJ, An SY. et al. Analysis of the prevalence and associated risk factors of tinnitus in adults. PLoS One 2015; 10 (05) e0127578
  • 4 Vijayakumar KA, Cho GW, Maharajan N, Jang CH. A review on peripheral tinnitus, causes, and treatments from the perspective of autophagy. Exp Neurobiol 2022; 31 (04) 232-242
  • 5 Lanaia V, Tziridis K, Schulze H. Salicylate-induced changes in hearing thresholds in Mongolian gerbils are correlated with tinnitus frequency but not with tinnitus strength. Front Behav Neurosci 2021; 15: 698516
  • 6 Hwang JH, Chen JC, Yang SY, Wang MF, Chan YC. Expression of tumor necrosis factor-α and interleukin-1β genes in the cochlea and inferior colliculus in salicylate-induced tinnitus. J Neuroinflammation 2011; 8: 30
  • 7 Klotz L, Enz R. MGluR7 is a presynaptic metabotropic glutamate receptor at ribbon synapses of inner hair cells. FASEB J 2021; 35 (11) e21855
  • 8 Jahan S, Redhu NS, Siddiqui AJ. et al. Nobiletin as a neuroprotectant against NMDA receptors: an in silico approach. Pharmaceutics 2022; 14 (06) 1123
  • 9 Hwang JH, Chen JC, Chan YC. Effects of C-phycocyanin and spirulina on salicylate-induced tinnitus, expression of NMDA receptor and inflammatory genes. PLoS One 2013; 8 (03) e58215
  • 10 Brozoski TJ, Wisner KW, Odintsov B, Bauer CA. Local NMDA receptor blockade attenuates chronic tinnitus and associated brain activity in an animal model. PLoS One 2013; 8 (10) e77674
  • 11 Ralli M, Troiani D, Podda MV. et al. The effect of the NMDA channel blocker memantine on salicylate-induced tinnitus in rats. Acta Otorhinolaryngol Ital 2014; 34 (03) 198-204
  • 12 Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol 2018; 141 (04) 1202-1207
  • 13 Lin Z, He H, Wang M, Liang J. MicroRNA-130a controls bone marrow mesenchymal stem cell differentiation towards the osteoblastic and adipogenic fate. Cell Prolif 2019; 52 (06) e12688
  • 14 Shen M, Li X, Qian B. et al. Crucial roles of microRNA-mediated autophagy in urologic malignancies. Int J Biol Sci 2021; 17 (13) 3356-3368
  • 15 Haque MM, Murale DP, Lee JS. Role of microRNA and oxidative stress in influenza a virus pathogenesis. Int J Mol Sci 2020; 21 (23) 8962
  • 16 Ferragut Cardoso AP, Banerjee M, Nail AN, Lykoudi A, States JC. miRNA dysregulation is an emerging modulator of genomic instability. Semin Cancer Biol 2021; 76: 120-131
  • 17 Wang X, He Y, Mackowiak B, Gao B. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. Gut 2021; 70 (04) 784-795
  • 18 Zhou SS, Jin JP, Wang JQ. et al. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges. Acta Pharmacol Sin 2018; 39 (07) 1073-1084
  • 19 Li Y, Li X, Wang L, Han N, Yin G. miR-375-3p contributes to hypoxia-induced apoptosis by targeting forkhead box P1 (FOXP1) and Bcl2 like protein 2 (Bcl2l2) in rat cardiomyocyte h9c2 cells. Biotechnol Lett 2021; 43 (02) 353-367
  • 20 Cheng S, Di Z, Hirman AR. et al. MiR-375-3p alleviates the severity of inflammation through targeting YAP1/LEKTI pathway in HaCaT cells. Biosci Biotechnol Biochem 2020; 84 (10) 2005-2013
  • 21 Han KH, Cho H, Han KR. et al. Role of microRNA–375–3p–mediated regulation in tinnitus development. Int J Mol Med 2021; 48 (01) 136
  • 22 Jang CH, Lee S, Park IY, Song A, Moon C, Cho GW. Memantine attenuates salicylate-induced tinnitus possibly by reducing NR2B expression in auditory cortex of rat. Exp Neurobiol 2019; 28 (04) 495-503
  • 23 Song A, Cho GW, Vijayakumar KA. et al. Neuroprotective effect of valproic acid on salicylate-induced tinnitus. Int J Mol Sci 2021; 23 (01) 23
  • 24 Spencer S, Mielczarek M, Olszewski J. et al. Effectiveness of bimodal auditory and electrical stimulation in patients with tinnitus: a feasibility study. Front Neurosci 2022; 16: 971633
  • 25 Kitano K, Yamashita A, Sugimura T. et al. Behavioral and immunohistochemical evidence for suppressive effects of Goshajinkigan on salicylate-induced tinnitus in rats. Brain Sci 2022; 12 (05) 587
  • 26 Wu C, Bao W, Yi B. et al. Increased metabolic activity and hysteretic enhanced GABAA receptor binding in a rat model of salicylate-induced tinnitus. Behav Brain Res 2019; 364: 348-355
  • 27 Wang J, Serratrice N, Lee CJ. et al. Physiopathological relevance of D-serine in the mammalian cochlea. Front Cell Neurosci 2021; 15: 733004
  • 28 Xiong S, Song Y, Liu J. et al. Neuroprotective effects of MK-801 on auditory cortex in salicylate-induced tinnitus: involvement of neural activity, glutamate and ascorbate. Hear Res 2019; 375: 44-52
  • 29 Ma R, Wang C, Wang J, Wang D, Xu J. miRNA-mRNA interaction network in non-small cell lung cancer. Interdiscip Sci 2016; 8 (03) 209-219
  • 30 Noroozi R, Dinger ME, Fatehi R, Taheri M, Ghafouri-Fard S. Identification of miRNA-mRNA network in autism spectrum disorder using a bioinformatics method. J Mol Neurosci 2021; 71 (04) 761-766
  • 31 van der Linden RJ, Gerritsen JS, Liao M. et al. RNA-binding protein ELAVL4/HuD ameliorates Alzheimer's disease-related molecular changes in human iPSC-derived neurons. Prog Neurobiol 2022; 217: 102316
  • 32 Dell'Orco M, Sardone V, Gardiner AS. et al. HuD regulates SOD1 expression during oxidative stress in differentiated neuroblastoma cells and sporadic ALS motor cortex. Neurobiol Dis 2021; 148: 105211
  • 33 Vanevski F, Xu B. HuD interacts with Bdnf mRNA and is essential for activity-induced BDNF synthesis in dendrites. PLoS One 2015; 10 (02) e0117264